» Articles » PMID: 39747283

Conformational Landscape of Soluble α-klotho Revealed by Cryogenic Electron Microscopy

Overview
Journal Sci Rep
Specialty Science
Date 2025 Jan 2
PMID 39747283
Authors
Affiliations
Soon will be listed here.
Abstract

α-Klotho (KLA) is a type-1 membranous protein that can associate with fibroblast growth factor receptor (FGFR) to form co-receptor for FGF23. The ectodomain of unassociated KLA is shed as soluble KLA (sKLA) to exert FGFR/FGF23-independent pleiotropic functions. The previously determined X-ray crystal structure of the extracellular region of sKLA in complex with FGF23 and FGFR1c suggests that sKLA functions solely as an on-demand coreceptor for FGF23. To understand the FGFR/FGF23-independent pleiotropic functions of sKLA, we investigated biophysical properties and structure of apo-sKLA. Single particle cryogenic electron microscopy (cryo-EM) revealed a 3.3 Å resolution structure of apo-sKLA that overlays well with its counterpart in the ternary complex with several distinct features. Compared to the ternary complex, the KL2 domain of apo-sKLA is more flexible. Three-dimensional variability analysis revealed that apo-sKLA adopts conformations with different KL1-KL2 interdomain bending and rotational angles. Mass photometry revealed that sKLA can form a stable structure with FGFR and/or FGF23 as well as sKLA dimer in solution. Cryo-EM supported the dimeric structure of sKLA. Recent studies revealed that FGF23 contains two KLA-binding sites. Our computational studies revealed that each site binds separate KLA in the dimer. The potential multiple forms and shapes of sKLA support its role as FGFR-independent hormone with pleiotropic functions. The ability of FGF23 to engage two KLA's simultaneously raises a potential new mechanism of action for FGF23-mediated signaling by the membranous klotho.

References
1.
Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T . Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997; 390(6655):45-51. DOI: 10.1038/36285. View

2.
Kim H, Nam B, Kim D, Kang M, Han J, Lee M . Circulating α-klotho levels in CKD and relationship to progression. Am J Kidney Dis. 2013; 61(6):899-909. DOI: 10.1053/j.ajkd.2013.01.024. View

3.
Hu M, Shi M, Zhang J, Quinones H, Griffith C, Kuro-O M . Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2010; 22(1):124-36. PMC: 3014041. DOI: 10.1681/ASN.2009121311. View

4.
Xie J, Yoon J, An S, Kuro-O M, Huang C . Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate. J Am Soc Nephrol. 2014; 26(5):1150-60. PMC: 4413766. DOI: 10.1681/ASN.2014040325. View

5.
Quarles L . Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease. Exp Cell Res. 2012; 318(9):1040-8. PMC: 3336874. DOI: 10.1016/j.yexcr.2012.02.027. View